All Eyes on the Legalization of Cannabis
NEW YORK, November 8, 2016 /PRNewswire/ --
Today is not only a politically important day for the United States, but also a very crucial day for marijuana industries, as many states will hold referendums on the decision to legalize recreational and medical marijuana or not. It is estimated that roughly 30 percent of the US population in nine of the states will partake in the vote for the historical decision. ChineseInvestors.com, Inc. (OTC: CIIX), Medicine Man Technologies, Inc. (OTC: MDCL), Cannabics Pharmaceuticals Inc. (OTC: CNBX), Cara Therapeutics Inc. (NASDAQ: CARA), Insys Therapeutics Inc. (NASDAQ: INSY).
According to a report by New Frontier and ArcView Market Research, the regulated cannabis market in the United States is projected to reach more than $7 billion this year. With many states voting today, all eyes will be focused on the Legalization of Cannabis.
Last week, ChineseInvestors.com Inc. (OTCQB: CIIX), announced that it will launch the world's first Chinese-language subscriber-only information service specifically focused on emerging growth companies in the Cannabis sector. The content of this service will cover the medical and recreational cannabis markets, the latest trends and technologies in the industry, and any investment opportunities in either private or publicly traded cannabis companies. The subscription service is expected to be launched after January 1st, 2017.
Just today ChineseInvestors.com Inc. announces that it will launch the world's first Chinese-language talk show specifically focused on investment opportunities in the Cannabis sector. The content of this talk show will follow the latest trends in both the medical and recreational cannabis markets, explore the promising growth of this new emerging industry, and identify select cannabis equities with the greatest potential for capital appreciation. The five-minute talk show is expected to be launched after December 1st, 2016, and it will be available on the company's official Youtube Channel as well as the Phoenix North America Chinese Channel, which is one of the most popular subscriber-only media platforms in the Chinese-speaking communities.
Warren Wang, founder and CEO of Chineseinvestors.com, commented: "Many Chinese investors still have a bias against the cultivation and sales of cannabis and we need to make them aware of the huge potential business opportunities within this industry. In addition, if recreational marijuana is legalized in California, an estimated $1 billion in new tax revenue would be directed toward specific drug use prevention programs and treatment, helping at-risk youth, law enforcement, and medical cannabis research In 2015, 1.8 million Chinese tourists visited United States. We believe that many of these tourists may be curious about the California cannabis legislation and may come to the state to either experience the American recreational marijuana culture or invest in this emerging market. Our plan to launch a first of its kind Chinese-language talk show focused specifically on the cannabis sector will definitely assist the Chinese-speaking investor in overcoming the language barrier and also help cannabis retailers to attract more potential medical users."
ChineseInvestors.com Inc. saw a great opportunity to enter the cannabis sector and holds or held a stake with consulting service company that covers all aspects of cannabis cultivation, Medicine Man Technologies, Inc. (OTCQB: MDCL). The company implemented a risk averse growing environment, applying high-tech indoor cannabis cultivation equipment and works in medical and adult use dispensaries. Medicine Man Technologies assisted Illinois and Nevada licensees to organize these practices after acquiring cultivation and dispensary operational licenses. Currently, the company has reinforced competitive application filings in Maryland and Hawaii and has pre-licensure clients in Texas, California, Florida, Ohio, Arkansas, and Oklahoma and has engaged potential clients in Alaska, Delaware, Utah, Michigan, Nebraska, Puerto Rico, and abroad.
Cannabics Pharmaceuticals Inc. (OTC: CNBX) announced results from the company's latest cancer HTS research overtly conclude that, depending upon the THC/CBD ratio, specific Cannabis extracts are directly contributive to reducing U87MG glioblastoma cell viability. "The Cannabics' method of diagnosis clearly differentiates between a multitude of varied plant extracts and their apoptotic and necrotic effects by utilizing state of the art of High Through-put Screening on cells derived from patients' biopsies; the results of which are visualized in "scans" of the before, during and after effect upon the cancer cells themselves" said Chief Scientist of Cannabics Pharmaceuticals, Dr. Eyal Ballan.
Biotechnology Company, Cara Therapeutics Inc. (NASDAQ: CARA), is pleased to be actively enrolling late stage studies with both IV and oral formulations of CR845 for three significant unmet medical indications. In September 2016, Cara initiated the enrollment of a Phase 2b trial of Oral CR845 in roughly 330 patients for the treatment of pain associated with osteoarthritis and presented positive data at PAINWeek from the Phase 2a study of Oral CR845 in OA. In October, company initiated Phase 1 study with Oral CR845 in hemodialysis patients.
Chairman, President and Chief Executive Officer of Insys Therapeutics Inc. (NASDAQ: INSY), Dr. John N. Kapoor has commented on the company's recent third quarter 2016 noting that Subsys volumes declined in the quarter, and is pleased to have maintained a mid-40 percent market share and believe the product will continue to provide a solid financial foundation for growth and to support the company's R&D efforts. The company is anticipating Drug Enforcement Administration scheduling of Syndros, it's recently FDA approved product for the treatment of cancer induced nausea and vomiting and anorexia related with weight loss in AIDS patients. INSY is excited about their main pipeline and believe that both its spray and cannabinoid platform products will provide opportunities for future growth.
Subscribe Now! Watch us report from NYSE https://www.youtube.com/FinancialBuzzMedia
For "The Latest Buzz in Financial News", SIGN UP & Visit: http://www.FinancialBuzz.com
Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR branding, marketing and advertising for third parties for disseminating news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.
For further information:
Media Contact: email@example.com , +1-877-601-1879